Which has stronger earnings & valuation, ACOG or GLAS?

Glass House Brands has higher revenue and earnings than Alpha Cognition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alpha Cognition $10.22M 19.39 -$20.67M -$1.10 N/A Glass House Brands $176.98M 2.89 N/A N/A N/A

Does the media prefer ACOG or GLAS?

In the previous week, Glass House Brands had 5 more articles in the media than Alpha Cognition. MarketBeat recorded 9 mentions for Glass House Brands and 4 mentions for Alpha Cognition. Alpha Cognition's average media sentiment score of 0.77 beat Glass House Brands' score of 0.51 indicating that Alpha Cognition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Cognition 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Glass House Brands 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ACOG or COLL?

In the previous week, Alpha Cognition had 1 more articles in the media than Collegium Pharmaceutical. MarketBeat recorded 4 mentions for Alpha Cognition and 3 mentions for Collegium Pharmaceutical. Alpha Cognition's average media sentiment score of 0.77 beat Collegium Pharmaceutical's score of 0.20 indicating that Alpha Cognition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Cognition 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Collegium Pharmaceutical 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, ACOG or IVA?

Alpha Cognition has higher revenue and earnings than Inventiva. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alpha Cognition $10.22M 19.39 -$20.67M -$1.10 N/A Inventiva $5.07M 145.85 -$400.67M N/A N/A

Does the media prefer ACOG or IVA?

In the previous week, Inventiva had 22 more articles in the media than Alpha Cognition. MarketBeat recorded 26 mentions for Inventiva and 4 mentions for Alpha Cognition. Alpha Cognition's average media sentiment score of 0.77 beat Inventiva's score of 0.07 indicating that Alpha Cognition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Cognition 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inventiva 4 Very Positive mention(s) 5 Positive mention(s) 9 Neutral mention(s) 6 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to ZVRA or ACOG?

In the previous week, Alpha Cognition had 3 more articles in the media than Zevra Therapeutics. MarketBeat recorded 4 mentions for Alpha Cognition and 1 mentions for Zevra Therapeutics. Alpha Cognition's average media sentiment score of 0.77 beat Zevra Therapeutics' score of 0.42 indicating that Alpha Cognition is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zevra Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alpha Cognition 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, ACOG or CRMD?

CorMedix has higher revenue and earnings than Alpha Cognition. Alpha Cognition is trading at a lower price-to-earnings ratio than CorMedix, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alpha Cognition $10.22M 19.39 -$20.67M -$1.10 N/A CorMedix $311.71M 1.80 $163.05M $2.14 3.36

Is ACOG or CRMD more profitable?

CorMedix has a net margin of 40.49% compared to Alpha Cognition's net margin of -153.61%. CorMedix's return on equity of 40.52% beat Alpha Cognition's return on equity. Company Net Margins Return on Equity Return on Assets Alpha Cognition -153.61% -54.60% -43.47% CorMedix 40.49% 40.52% 20.61%

Does the media prefer ACOG or CRMD?

In the previous week, Alpha Cognition had 3 more articles in the media than CorMedix. MarketBeat recorded 4 mentions for Alpha Cognition and 1 mentions for CorMedix. CorMedix's average media sentiment score of 0.82 beat Alpha Cognition's score of 0.77 indicating that CorMedix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Cognition 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorMedix 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Alpha Cognition (ACOG) Competitors

$9.10 +0.40 (+4.60%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$9.24 +0.15 (+1.59%)

As of 10/2/2026 07:30 PM Eastern

Compare

ACOG vs. GLAS, COLL, IVA, ZVRA, and CRMD

Should you buy Alpha Cognition stock or one of its competitors? Alpha Cognition's main competitors and comparable companies include Glass House Brands (GLAS), Collegium Pharmaceutical (COLL), Inventiva (IVA), Zevra Therapeutics (ZVRA), and CorMedix (CRMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Alpha Cognition compare to Glass House Brands?

Alpha Cognition (NASDAQ:ACOG) and Glass House Brands (NYSE:GLAS) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

Glass House Brands has higher revenue and earnings than Alpha Cognition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Cognition	$10.22M	19.39	-$20.67M	-$1.10	N/A
Glass House Brands	$176.98M	2.89	N/A	N/A	N/A

In the previous week, Glass House Brands had 5 more articles in the media than Alpha Cognition. MarketBeat recorded 9 mentions for Glass House Brands and 4 mentions for Alpha Cognition. Alpha Cognition's average media sentiment score of 0.77 beat Glass House Brands' score of 0.51 indicating that Alpha Cognition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Cognition	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Glass House Brands	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Glass House Brands has a net margin of 0.00% compared to Alpha Cognition's net margin of -153.61%. Glass House Brands' return on equity of 0.00% beat Alpha Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Cognition	-153.61%	-54.60%	-43.47%
Glass House Brands	N/A	N/A	N/A

Alpha Cognition presently has a consensus target price of $18.00, suggesting a potential upside of 97.80%. Glass House Brands has a consensus target price of $16.00, suggesting a potential upside of 193.42%. Given Glass House Brands' higher possible upside, analysts clearly believe Glass House Brands is more favorable than Alpha Cognition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Glass House Brands	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Glass House Brands beats Alpha Cognition on 6 of the 10 factors compared between the two stocks.

How does Alpha Cognition compare to Collegium Pharmaceutical?

Alpha Cognition (NASDAQ:ACOG) and Collegium Pharmaceutical (NASDAQ:COLL) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations.

In the previous week, Alpha Cognition had 1 more articles in the media than Collegium Pharmaceutical. MarketBeat recorded 4 mentions for Alpha Cognition and 3 mentions for Collegium Pharmaceutical. Alpha Cognition's average media sentiment score of 0.77 beat Collegium Pharmaceutical's score of 0.20 indicating that Alpha Cognition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Cognition	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Collegium Pharmaceutical	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Collegium Pharmaceutical has a net margin of 5.93% compared to Alpha Cognition's net margin of -153.61%. Collegium Pharmaceutical's return on equity of 91.43% beat Alpha Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Cognition	-153.61%	-54.60%	-43.47%
Collegium Pharmaceutical	5.93%	91.43%	15.57%

Alpha Cognition has a beta of 2.32, suggesting that its stock price is 132% more volatile than the broader market. Comparatively, Collegium Pharmaceutical has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market.

Collegium Pharmaceutical has higher revenue and earnings than Alpha Cognition. Alpha Cognition is trading at a lower price-to-earnings ratio than Collegium Pharmaceutical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Cognition	$10.22M	19.39	-$20.67M	-$1.10	N/A
Collegium Pharmaceutical	$808.21M	0.89	$62.87M	$1.24	17.76

Alpha Cognition currently has a consensus target price of $18.00, indicating a potential upside of 97.80%. Collegium Pharmaceutical has a consensus target price of $48.71, indicating a potential upside of 121.23%. Given Collegium Pharmaceutical's higher possible upside, analysts plainly believe Collegium Pharmaceutical is more favorable than Alpha Cognition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Collegium Pharmaceutical	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Summary

Collegium Pharmaceutical beats Alpha Cognition on 9 of the 14 factors compared between the two stocks.

How does Alpha Cognition compare to Inventiva?

Alpha Cognition (NASDAQ:ACOG) and Inventiva (NASDAQ:IVA) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings, valuation and media sentiment.

19.1% of Inventiva shares are owned by institutional investors. 8.6% of Alpha Cognition shares are owned by company insiders. Comparatively, 32.0% of Inventiva shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Inventiva had 22 more articles in the media than Alpha Cognition. MarketBeat recorded 26 mentions for Inventiva and 4 mentions for Alpha Cognition. Alpha Cognition's average media sentiment score of 0.77 beat Inventiva's score of 0.07 indicating that Alpha Cognition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Cognition	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inventiva	4 Very Positive mention(s)	5 Positive mention(s)	9 Neutral mention(s)	6 Negative mention(s)	0 Very Negative mention(s)	Neutral

Inventiva has a net margin of 0.00% compared to Alpha Cognition's net margin of -153.61%. Inventiva's return on equity of 0.00% beat Alpha Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Cognition	-153.61%	-54.60%	-43.47%
Inventiva	N/A	N/A	N/A

Alpha Cognition has a beta of 2.32, suggesting that its share price is 132% more volatile than the broader market. Comparatively, Inventiva has a beta of 0.79, suggesting that its share price is 21% less volatile than the broader market.

Alpha Cognition has higher revenue and earnings than Inventiva.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Cognition	$10.22M	19.39	-$20.67M	-$1.10	N/A
Inventiva	$5.07M	145.85	-$400.67M	N/A	N/A

Alpha Cognition currently has a consensus target price of $18.00, indicating a potential upside of 97.80%. Inventiva has a consensus target price of $15.86, indicating a potential upside of 345.43%. Given Inventiva's higher probable upside, analysts plainly believe Inventiva is more favorable than Alpha Cognition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Inventiva	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	3.00

Summary

Inventiva beats Alpha Cognition on 10 of the 14 factors compared between the two stocks.

How does Alpha Cognition compare to Zevra Therapeutics?

Zevra Therapeutics (NASDAQ:ZVRA) and Alpha Cognition (NASDAQ:ACOG) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

Zevra Therapeutics has a net margin of 42.82% compared to Alpha Cognition's net margin of -153.61%. Zevra Therapeutics' return on equity of 54.54% beat Alpha Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zevra Therapeutics	42.82%	54.54%	34.15%
Alpha Cognition	-153.61%	-54.60%	-43.47%

35.0% of Zevra Therapeutics shares are held by institutional investors. 3.7% of Zevra Therapeutics shares are held by insiders. Comparatively, 8.6% of Alpha Cognition shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Zevra Therapeutics has a beta of 0.98, suggesting that its stock price is 2% less volatile than the broader market. Comparatively, Alpha Cognition has a beta of 2.32, suggesting that its stock price is 132% more volatile than the broader market.

Zevra Therapeutics currently has a consensus target price of $27.14, indicating a potential upside of 171.70%. Alpha Cognition has a consensus target price of $18.00, indicating a potential upside of 97.80%. Given Zevra Therapeutics' higher possible upside, equities research analysts plainly believe Zevra Therapeutics is more favorable than Alpha Cognition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zevra Therapeutics	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.00
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

Zevra Therapeutics has higher revenue and earnings than Alpha Cognition. Alpha Cognition is trading at a lower price-to-earnings ratio than Zevra Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zevra Therapeutics	$106.47M	5.57	$83.23M	$0.92	10.86
Alpha Cognition	$10.22M	19.39	-$20.67M	-$1.10	N/A

In the previous week, Alpha Cognition had 3 more articles in the media than Zevra Therapeutics. MarketBeat recorded 4 mentions for Alpha Cognition and 1 mentions for Zevra Therapeutics. Alpha Cognition's average media sentiment score of 0.77 beat Zevra Therapeutics' score of 0.42 indicating that Alpha Cognition is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zevra Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Cognition	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Zevra Therapeutics beats Alpha Cognition on 11 of the 16 factors compared between the two stocks.

How does Alpha Cognition compare to CorMedix?

Alpha Cognition (NASDAQ:ACOG) and CorMedix (NASDAQ:CRMD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment.

CorMedix has higher revenue and earnings than Alpha Cognition. Alpha Cognition is trading at a lower price-to-earnings ratio than CorMedix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Cognition	$10.22M	19.39	-$20.67M	-$1.10	N/A
CorMedix	$311.71M	1.80	$163.05M	$2.14	3.36

In the previous week, Alpha Cognition had 3 more articles in the media than CorMedix. MarketBeat recorded 4 mentions for Alpha Cognition and 1 mentions for CorMedix. CorMedix's average media sentiment score of 0.82 beat Alpha Cognition's score of 0.77 indicating that CorMedix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Cognition	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorMedix	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

34.2% of CorMedix shares are owned by institutional investors. 8.6% of Alpha Cognition shares are owned by company insiders. Comparatively, 3.5% of CorMedix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

CorMedix has a net margin of 40.49% compared to Alpha Cognition's net margin of -153.61%. CorMedix's return on equity of 40.52% beat Alpha Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Cognition	-153.61%	-54.60%	-43.47%
CorMedix	40.49%	40.52%	20.61%

Alpha Cognition currently has a consensus target price of $18.00, indicating a potential upside of 97.80%. CorMedix has a consensus target price of $15.00, indicating a potential upside of 108.62%. Given CorMedix's higher probable upside, analysts clearly believe CorMedix is more favorable than Alpha Cognition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
CorMedix	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

Alpha Cognition has a beta of 2.32, suggesting that its stock price is 132% more volatile than the broader market. Comparatively, CorMedix has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market.

Summary

CorMedix beats Alpha Cognition on 11 of the 16 factors compared between the two stocks.

Get Alpha Cognition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACOG vs. The Competition

Export

Metric	Alpha Cognition	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$189.47M	$12.27B	$7.13B	$13.14B
Dividend Yield	N/A	2.64%	2.53%	16.77%
P/E Ratio	-8.27	794.62	273.77	26.04
Price / Sales	19.39	839.20	614.30	85.58
Price / Cash	N/A	82.26	77.60	51.75
Price / Book	3.16	10.46	10.92	6.30
Net Income	-$20.67M	$2.83B	$3.50B	$361.43M
7 Day Performance	7.44%	-1.56%	-2.07%	-1.67%
1 Month Performance	-1.19%	-5.67%	-6.21%	-4.51%
1 Year Performance	21.66%	-4.72%	7.45%	2.03%

Alpha Cognition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACOG Alpha Cognition	4.2815 of 5 stars	$9.10 +4.6%	$18.00 +97.8%	+22.3%	$189.47M	$10.22M	N/A	71	News Coverage
GLAS Glass House Brands	2.9692 of 5 stars	$7.82 -2.4%	$16.00 +104.7%	N/A	$733.33M	$176.98M	N/A	357	Options Volume High Trading Volume
COLL Collegium Pharmaceutical	4.1411 of 5 stars	$22.45 -1.4%	$48.71 +117.0%	-35.8%	$730.97M	$780.57M	18.10	423
IVA Inventiva	3.4108 of 5 stars	$3.45 -5.5%	$15.75 +356.5%	-43.5%	$716.60M	$5.07M	N/A	73	News Coverage Earnings Report Analyst Forecast Gap Up High Trading Volume
ZVRA Zevra Therapeutics	4.5028 of 5 stars	$11.32 -2.2%	$27.14 +139.8%	+7.3%	$672.18M	$106.47M	12.30	61

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ACOG) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alpha Cognition (ACOG) Competitors

ACOG vs. GLAS, COLL, IVA, ZVRA, and CRMD

How does Alpha Cognition compare to Glass House Brands?

Summary

How does Alpha Cognition compare to Collegium Pharmaceutical?

Summary

How does Alpha Cognition compare to Inventiva?

Summary

How does Alpha Cognition compare to Zevra Therapeutics?

Summary

How does Alpha Cognition compare to CorMedix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACOG vs. The Competition

Alpha Cognition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alpha Cognition (ACOG) Competitors

ACOG vs. GLAS, COLL, IVA, ZVRA, and CRMD

How does Alpha Cognition compare to Glass House Brands?

Which has stronger earnings & valuation, ACOG or GLAS?

Does the media prefer ACOG or GLAS?

Is ACOG or GLAS more profitable?

Do analysts rate ACOG or GLAS?

Summary

How does Alpha Cognition compare to Collegium Pharmaceutical?

Does the media refer more to ACOG or COLL?

Is ACOG or COLL more profitable?

Which has more volatility and risk, ACOG or COLL?

Which has higher earnings & valuation, ACOG or COLL?

Do analysts rate ACOG or COLL?

Summary

How does Alpha Cognition compare to Inventiva?

Do insiders and institutionals have more ownership in ACOG or IVA?

Does the media prefer ACOG or IVA?

Is ACOG or IVA more profitable?

Which has more risk and volatility, ACOG or IVA?

Which has stronger earnings and valuation, ACOG or IVA?

Do analysts rate ACOG or IVA?

Summary

How does Alpha Cognition compare to Zevra Therapeutics?

Is ZVRA or ACOG more profitable?

Do insiders & institutionals believe in ZVRA or ACOG?

Which has more risk and volatility, ZVRA or ACOG?

Do analysts prefer ZVRA or ACOG?

Which has better valuation & earnings, ZVRA or ACOG?

Does the media refer more to ZVRA or ACOG?

Summary

How does Alpha Cognition compare to CorMedix?

Which has preferable earnings & valuation, ACOG or CRMD?

Does the media prefer ACOG or CRMD?

Do institutionals and insiders have more ownership in ACOG or CRMD?

Is ACOG or CRMD more profitable?

Do analysts rate ACOG or CRMD?

Which has more volatility & risk, ACOG or CRMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACOG vs. The Competition

Alpha Cognition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools